Fernand Labrie
Publications
Page 1 of 8, showing 50 records out of 361 total, starting on record 1, ending on 50
| Publication | Category | Year |
|---|---|---|
| 361. Asselin, J., Labrie, F., Gourdeau, Y., Bonne, C., Raynaud, J.P. (1976) Binding of [3H]methyltrienolone (Rl88l) in rat prostate and human benign prostatic hypertrophy (BPH). Steroids, 28: 449-459. | Prostate Cancer | 1976 |
| 360. Coy, D.H., Labrie, F., Savary, M., Coy, E.J., Schally, A.V. (1976) Antagonistic activity of analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. Mol. Cell. Endocrinol., 5: 201-208. | Prostate Cancer | 1976 |
| 359. Ferland, L., Labrie, F., Savary, M., Beaulieu, M., Coy, D.H., Coy, E.J., Schally, A.V. (1976) Inhibitory activity of analogues of luteinizing hormone-releasing hormone (LH-RH) in vitro and in vivo. Clin. Endocrinol. (Oxf.), 5: 279S-289S. | Prostate Cancer | 1976 |
| 358. Labrie, F., Savary, M., Coy, D.H., Coy, E.J., Schally, A.V. (1976) Inhibition of luteinizing hormone release by analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. Endocrinology, 98: 289-94. | Prostate Cancer | 1976 |
| 357. Auclair, C., Kelly, P.A., Coy, D.H., Schally, A.V., Labrie, F. (1977) Potent inhibitory activity of [D-Leu6, des-Gly-NH2 10]ethylamide on LH/hCG and PRL testicular receptor levels in the rat. Endocrinology, 101: 1890-1893. | Prostate Cancer | 1977 |
| 356. Auclair, C., Kelly, P.A., Labrie, F., Coy, D.H., Schally, A.V. (1977) Inhibition of testicular LH/hCG receptor level by treatment with a potent LHRH agonist or hCG. Biochem. Biophys. Res. Commun., 76: 855-862. | Prostate Cancer | 1977 |
| 355. Labrie, F., Ferland, L., Lagacé, L., Drouin, J., Asselin, J., Azadian-Boulanger, G., Raynaud, J.P. (1977) High inhibitory activity of R5020, a pure progestin, at the hypothalamic-adenohypophyseal level on gonadotropin secretion. Fertil. Steril., 28: 1104-1112. | Prostate Cancer | 1977 |
| 354. Auclair, C., Cusan, L., Kledzik, G.S., Ferland, L., Kelly, P.A., Labrie, F. (1978) Inhibition de fonctions gonadiques par la LHRH et ses agonistes chez le rat mâle et femelle. Union Med. Can., 107: 356-364. | Prostate Cancer | 1978 |
| 353. Auclair, C., Ferland, L., Cusan, L., Kelly, P.A., Labrie, F., Azadian-Boulanger, G., Raynaud, J.P. (1978) Effet inhibiteur de la LHRH sur les récepteurs de la LH dans le testicule chez le rat. C.R. Acad. Sci. Hebd. Seances Acad. Sci. D, 286: 1305-1307. | Prostate Cancer | 1978 |
| 352. Labrie, F., Auclair, C., Cusan, L., Kelly, P.A., Pelletier, G., Ferland, L. (1978) Inhibitory effect of LHRH and its agonists on testicular gonadotropin receptors and spermatogenesis in the rat, in: Hansson, V., ed. 5th Ann. Workshop on the Testis: Endocrine Approach to Male Contraception, Hvidoure, Denmark, Int. J. of Andrology. Scriptor Publisher APS, pp 303-318. | Prostate Cancer | 1978 |
| 351. Pelletier, G., Cusan, L., Auclair, C., Kelly, P.A., Désy, L., Labrie, F. (1978) Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, des-Gly-NH210]LHRH ethylamide. Endocrinology, 103: 641-643. | Prostate Cancer | 1978 |
| 350. Bélanger, A., Auclair, C., Séguin, C., Kelly, P.A., Labrie, F. (1979) Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin. Mol. Cell. Endocrinol., 13: 47-53. | Prostate Cancer | 1979 |
| 349. Cusan, L., Auclair, C., Bélanger, A., Ferland, L., Kelly, P.A., Séguin, C., Labrie, F. (1979) Inhibitory effects of long-term treatment with an LHRH agonist on the pituitary-gonadal axis in male and female rats. Endocrinology, 104: 1369-1376. | Prostate Cancer | 1979 |
| 348. Labrie, F., Auclair, C., Cusan, L., Lemay, A., Pelletier, G., Kelly, P.A., Bélanger, A., Séguin, C., Raynaud, J.P. (1979) Antifertility effects of LHRH and its agonists in male and female rats: possible luteolytic effects of LHRH in women, in: Talwar, G.P., ed. Recent Advances in Reproduction and Regulation of Fertility, Elsevier-North Holland, Biomedical Press, pp 57-71. | Prostate Cancer | 1979 |
| 347. Raynaud, J.P., Bonne, C., Bouton, M.M., Lagacé, L., Labrie, F. (1979) Action of a non -steroidal anti -androgen, RU23908, in peripheral and central tissues. J. Steroid Biochem., 11: 93-99. | Prostate Cancer | 1979 |
| 346. Bélanger, A., Auclair, C., Ferland, L., Caron, S., Labrie, F. (1980) Time-course of the effect of treatment with a potent LHRH agonist on testicular steroidogenesis and gonadotropin receptor levels in the adult rat. J. Steroid Biochem., 13: 191-196. | Prostate Cancer | 1980 |
| 345. Bélanger, A., Cusan, L., Auclair, C., Séguin, C., Caron, S., Labrie, F. (1980) Effect of an LHRH agonist and hCG on testicular steroidogenesis in the adult rat. Biol. Reprod., 22: 1094-1101. | Prostate Cancer | 1980 |
| 344. Bélanger, A., Cusan, L., Séguin, C., Caron, S., Labrie, F. (1980) Inhibition de la stéroïdogénèse testiculaire chez le rat par traitement avec un agoniste de la LHRH. Union Med. Can., 109: 489-494. | Prostate Cancer | 1980 |
| 343. Belanger, A., Labrie, F., Lemay, A., Caron, S., Raynaud, J.P. (1980) Inhibitory effects of a single intranasal administration of [D-Ser(TBU)6, des-Gly -NH210]LHRH ethylamide, a potent LHRH agonist, on serum steroid levels in normal adult men. J. Steroid Biochem., 13: 123-126. | Prostate Cancer | 1980 |
| 342. Labrie, F., Bélanger, A., Cusan, L., Séguin, C., Pelletier, G., Kelly, P.A., Reeves, J.J., Lefebvre, F.A., Lemay, A., Raynaud, J.P. (1980) Antifertility effects of LHRH agonists in the male. J. Androl., 1: 209-228. | Prostate Cancer | 1980 |
| 341. Labrie, F., Bélanger, A., Pelletier, G., Séguin, C., Cusan, L., Kelly, P.A., Lemay, A., Auclair, C., Raynaud, J.P. (1980) LHRH agonists: inhibition of testicular functions and possible clinical applications, in: Cunningham, G.R., Schill, W.B. et Hafez, E.S.E., eds: Clinics in Andrology. Regulation of Male Fertility, The Netherlands, Martinus Nijoff Publ., B.V., The Hague, pp 65-75. | Prostate Cancer | 1980 |
| 340. Labrie, F., Cusan, L., Séguin, C., Bélanger, A., Pelletier, G., Reeves, J., Kelly, P.A., Lemay, A., Raynaud, J.P. (1980) Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man. Int. J. Fertil., 25: 157-170. | Prostate Cancer | 1980 |
| 339. Pelletier, G., Cusan, L., Bélanger, A., Séguin, C., Kelly, P.A., Labrie, F. (1980) Further studies on the inhibitory effects of [D-Ala6, des-Gly-NH210]LHRH ethylamide on spermatogenesis and steroidogenesis in the rat: Reversibility and effect of androgen administration. J. Androl., 1: 171-181. | Prostate Cancer | 1980 |
| 338. Bélanger, A., Auclair, C., Séguin, C., Caron, S., Labrie, F. (1981) Prolactin stimulation of testicular steroid biosynthesis in the male rat. J. Androl., 2: 80-86. | Prostate Cancer | 1981 |
| 337. Bélanger, A., Caron, S., Cusan, L., Séguin, C., Auclair, C., Labrie, F. (1981) Inhibition of testicular androgen biosynthesis by treatment with LHRH agonists, in: McKerns, K.W., ed. Reproductive Processes and Contraception. International Society for Biochemical Endocrinology, New York, Plenum Press, pp 471-491. | Prostate Cancer | 1981 |
| 336. Faure, N., Lemay, A., Bélanger, A., Labrie, F. (1981) Inhibition of androgen biosynthesis in the human male by chronic administration of [D-Ser(TBU)6]-des-Gly-NH210]LHRH ethylamide, in: Zatuchni, G.I., Shelton, J.D. et Sciarra, J.J., eds: LHRH peptides as female and male contraceptive, Philadelphia, Harper & Row, pp 307-320. | Prostate Cancer | 1981 |
| 335. Labrie, F. (1981) Changing the message from the brain. People, 8: 16-17. | Prostate Cancer | 1981 |
| 334. Labrie, F., Bélanger, A., Kelly, P.A., Séguin, C., Cusan, L., Lefebvre, F.A., Reeves, J.J., Lemay, A., Faure, N., Laroche, B., Raynaud, J.P. (1981) Antifertility effects of LHRH agonists, in: Soto, R.J., De Nicola, A.F. et Blaquier, J.A., eds: Progress in Clinical and Biological Research. Physiopathology of Diseases and Mechanisms of Hormone Action, New York, Alan R. Liss Inc., pp 273-291. | Prostate Cancer | 1981 |
| 333. Labrie, F., Bélanger, A., Séguin, C., Cusan, L., Pelletier, G., Lefebvre, F.A., Kelly, P.A., Ferland, L., Reeves, J.J., Lemay, A., Raynaud, J.P. (1981) Inhibition of testicular and ovarian functions by LHRH agonists, in: Jagiello, G. et Vogel, H.J., eds: Bioregulators of Reproduction, New York, NY, USA, Academic Press, pp 305-341. | Prostate Cancer | 1981 |
| 332. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Kelly, P.A., Lefebvre, F.A., Massicotte, J., Borgus, J.P., Lemay, A., van der Ohe, M. (1981) Antifertility effects of LHRH agonists, in: Semm, K. et Mettler, L., eds: Proc. III World Congress on Human Reproduction, Excerta Medica, ICS 551, pp 116-125. | Prostate Cancer | 1981 |
| 331. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Lefebvre, F.A., Massicotte, J., Kelly, P.A., Borgus, J.P. (1981) LHRH and sexual functions: inhibition at the pituitary and gonadal levels, in: Bizollon, C.A., ed. Physiological peptides and new trends in radioimmunology, Elsevier-North Holland, Biomedical Press, pp 57-70. | Prostate Cancer | 1981 |
| 330. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Lefebvre, F.A., Reeves, J.J., Kelly, P.A., Massicotte, J., Cusan, L. (1981) LHRH and down regulation of testicular receptors and function, in: Frajese, G., ed. Oligospermia. Recent Progress in Andrology, New York, NY, USA, Raven Press, pp 337-345. | Prostate Cancer | 1981 |
| 329. Labrie, F., Godbout, M., Bélanger, A., Lefebvre, F.A., Séguin, C., Pelletier, G., Cusan, L., Kelly, P.A., Reeves, J.J. (1981) Mechanisms of the antifertility effects of LHRH agonists in the male rat, in: Shelton, J.D., Zatuchni, G.I. et Sciarra, J.J., eds: LHRH peptides as female and male contraceptives, Philadelphia, Harper & Row, pp 246-260. | Prostate Cancer | 1981 |
| 328. Séguin, C., Bélanger, A., Cusan, L., Pelletier, G., Reeves, J.J., Lefebvre, F.A., Kelly, P.A., Labrie, F. (1981) Relative importance of the adenohypophyseal and gonadal sites of inhibitory action of LHRH agonists. Biol. Reprod., 24: 889-901. | Prostate Cancer | 1981 |
| 327. Séguin, C., Cusan, L., Bélanger, A., Kelly, P.A., Labrie, F., Raynaud, J.P. (1981) Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat. Mol. Cell. Endocrinol., 21: 37-41. | Prostate Cancer | 1981 |
| 326. Carmichael, R., Bélanger, A., Caron, S., Labrie, F., Sairam, M.R. (1982) Comparative effects of LHRH agonist and ovine LH administration on testicular steroidogenesis in intact adult rat. Steroids, 40: 641-649. | Prostate Cancer | 1982 |
| 325. Faure, N., Labrie, F., Belanger, A., Lemay, A., Raynaud, J.P., Von der Ohe, M., Fazekas, A.T. (1982) Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (HOE-766) in young normal adult men. J. Endocrinol. Invest., 5: 355-360. | Prostate Cancer | 1982 |
| 324. Faure, N., Labrie, F., Lemay, A., Bélanger, A., Gourdeau, Y., Laroche, B., Robert, G. (1982) Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent LHRH agonist in adult men. Fertil. Steril., 37: 416-424. | Prostate Cancer | 1982 |
| 323. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Lacourcière, Y., Monfette, G., Laberge, J.G., Emond, J., Fazekas, A.T.A., Raynaud, J.P., Husson, J.M. (1982) New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and antiandrogen. Clin. Invest. Med., 5: 267-275. | Prostate Cancer | 1982 |
| 322. Lefebvre, F.A., Séguin, C., Bélanger, A., Caron, S., Sairam, M.R., Raynaud, J.P., Labrie, F. (1982) Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat. Prostate, 3: 569-578. | Prostate Cancer | 1982 |
| 321. Resko, J., Bélanger, A., Labrie, F. (1982) Effects of chronic treatment with a potent LHRH agonist on serum LH and steroid levels in the male rhesus monkey. Biol. Reprod., 26: 378-384. | Prostate Cancer | 1982 |
| 320. Tolis, G., Ackman, D., Stellos, A., Mehta, A., Labrie, F., Fazekas, A.T.A., Comaru-Schally, A.M., Schally, A.V. (1982) Tumor growth inhibition in patients with prostatic caricnoma treated with luteinizing hormone-releasing hormone agonists. Proc. Natl. Acad. Sci. USA, 79: 1658-1662. | Prostate Cancer | 1982 |
| 319. Bélanger, A., Labrie, F., Séguin, C., Cusan, L., Carmichael, R., Caron, S. (1983) Inhibition of testicular delta 4-androgen secretion in the rat by treatment with luteinizing hormone-releasing hormone, in: Negro-Vilar, A., ed. Male Reproduction and Fertility, New York, Raven Press, pp 127-139. | Prostate Cancer | 1983 |
| 318. Labrie, F. (1983) A new therapy in prostatic cancer. Urology Times, August. | Prostate Cancer | 1983 |
| 317. Labrie, F. (1983) Luteinizing hormone-releasing hormone agonists and fertility regulation. The 9th Jennifer Hallam Memorial Lecture. J. Obst. Gynecol., 3: S37-S46. | Prostate Cancer | 1983 |
| 316. Labrie, F., Bélanger, A., Carmichael, R., Séguin, C., Lefebvre, F.A., Faure, N., Dupont, A. (1983) Inhibition of the testicular steroidogenic pathway in experimental animals and men, in: D'Agata, R., Lipsett, M.B.,Polosa, P. et van der Molen, H.J., eds: Recent Advances in Male Reproduction: Molecular Basis and Clinical Implications, New York, Raven Press, pp 239-248. | Prostate Cancer | 1983 |
| 315. Labrie, F., Dupont, A., Bélanger, A., Husson, J.M., Raynaud, J.P. (1983) Nouveau traitement antihormonal avec un antiandrogène et un agoniste de la LHRH dans le cancer de la prostate. Ann. Endocrinol. (Paris), 44: 343-344. | Prostate Cancer | 1983 |
| 314. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Raynaud, J.P., Husson, J.M., Gareau, J., Fazekas, A.T.A., Sandow, J., Monfette, G. (1983) New approach in the treatment of prostate cancer: complete instead of only partial withdrawal of androgens. Prostate, 4: 579-594. | Prostate Cancer | 1983 |
| 313. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Cusan, L., Monfette, G., Laberge, J.G., Emond, J.P., Raynaud, J.P., Husson, J.M., Fazekas, A.T.A. (1983) New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogen. J. Steroid Biochem., 19: 999-1007. | Prostate Cancer | 1983 |
| 312. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Cusan, L., Raynaud, J.P., Husson, J.M., Fazekas, A.T. (1983) New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist. Horm. Res., 18: 18-27. | Prostate Cancer | 1983 |